BioStock Investor Pitch: Spermosens

Swedish Spermosens’ vision is to improve diagnostics within the area of male infertility and thus help improve IVF treatments. Using the company’s JUNO-Checked system the sperm’s ability to bond to the egg cell can be tested and the result can help clinicians determine the best treatment course making IVF-treatments more efficient. CEO Ulrik Nilsson visited BioStock’s studio to present the company, its product, and the development plan.

See the presentation at biostock.se:

https://www.biostock.se/en/2023/01/biostock-investor-pitch-spermosens/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/